| Biologic Therapy |
1 |
1 |
| Muscular Atrophy |
0 |
0.9 |
| Amyotrophic Lateral Sclerosis |
0 |
0.99 |
| Liver |
0 |
0.29 |
| Liver Disease |
0 |
0.27 |
| Board Certification |
0 |
0.19 |
| Washington |
0 |
0.19 |
| Adverse Effects |
0 |
0.1 |
| Antioxidant |
0 |
0.1 |
| Artificial Intelligence |
0 |
0.1 |
| Disease-Modifying Therapy |
0 |
0.1 |
| Food and Drug Administration (FDA) |
0 |
0.1 |
| Generics |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Nerve |
0 |
0.1 |
| Patient Safety |
0 |
0.1 |
| Plasma |
0 |
0.1 |
| Toxicology |
0 |
0.1 |